Your browser doesn't support javascript.
loading
T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Chen, Cunte; Huang, Ling; Liu, Sichu; Jiang, Xinmiao; Chen, Feili; Wei, Xiaojuan; Guo, Hanguo; Zeng, Xiangbo; Zeng, Chengwu; Przybylski, Grzegorz K; Li, Wenyu; Li, Yangqiu.
Afiliación
  • Chen C; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Huang L; Department of Hematology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
  • Liu S; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Jiang X; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Chen F; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Wei X; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Guo H; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zeng X; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zeng C; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Przybylski GK; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
  • Li W; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Li Y; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Asia Pac J Clin Oncol ; 20(1): 81-86, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37635422
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T / Linfoma de Células T Periférico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Asia Pac J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T / Linfoma de Células T Periférico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Asia Pac J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China